Ansun Biopharma Stock

ansunbiopharma.comHealthcare / BioTech & PharmaFounded: 2003Funding to Date: $165.2MM

Ansun Biopharma, founded in 2003, is a biopharmaceutical company seeking to develop innovative antiviral therapies. Ansun Biopharma's therapy is designed with the goal of utilizing a host-directed anti-viral biological product that aims to treat respiratory viral infections such as influenza virus, para influenza virus, and metapneumovirus. Ansun Biopharma is headquartered in San Diego, California.

Register To Buy and Sell Shares

For more details on financing and valuation for Ansun Biopharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Ansun Biopharma’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Ansun Biopharma.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Nancy Chang Ph.D
Chief Executive Officer & Chairperson of the Board
Ivy Fan
George Wang
Chief Technology Officer
Mikael Havluciyan
Chief Legal Officer & Corporate Secretary
Stanley Lewis MD
Chief Medical Officer

Board Members

Allen Chao Ph.D
Karen Liu Ph.D
Nancy Chang Ph.D
Aimin Wu
Sinopharm Healthcare Fund
Donald Payne
Michael Chao MD
Dave Chenn
Michael Chang Ph.D
Yi Shi Ph.D
Lilly Asia Ventures

Frequently Asked Questions About Ansun Biopharma’s Stock

Can you buy Ansun Biopharma’s stock?
Ansun Biopharma is not publicly traded on NYSE or NASDAQ in the U.S. To buy Ansun Biopharma’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Ansun Biopharma’s stock?
Yes, you can sell stock of a private company like Ansun Biopharma. Forge can help you sell your Ansun Biopharma stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Ansun Biopharma’s stock price?
Ansun Biopharma is a privately held company and therefore does not have a public stock price. However, you may access Ansun Biopharma’s private market stock price with Forge Data.
What is Ansun Biopharma’s stock ticker symbol?
Ansun Biopharma does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Chinese biotech firm Ansun BioPharma secures $80m Series B financing
Ansun aims to drive the global Phase 3 clinical trial of its experimental anti-viral medication.
Updated on: Feb 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.